T0	Citation 1485 1487	37
T1	Context 1363 1489	Furthermore, inhibition of mTOR by rapamycin can slow or block AD progression in a transgenic mouse model of the disease [37].
T2	ACCURATE 3049 3347	Our data suggest that inhibition of mTOR by rapamycin, an intervention that extends lifespan in mice, can slow or block AD progression in a transgenic mouse model of the disease. Rapamycin, already used in clinical settings, may be a potentially effective therapeutic agent for the treatment of AD.
